Options Brief: Alkermes

Shares of Alkermes ALKS are higher on the session by 3.64%, trading at $17.53. Overall call volume is now running at 7.27x the daily average, with 0% of all calls traded being purchases on the offer. 1,860 contracts have traded on the session so far. Alkermes, Inc. is an integrated biotechnology company. The company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases.